Minhua Peng et al. have also reported the anti-dengue efficacy of the TXNIP degrader Luteolin [48], demonstrating that TXNIP intervention indeed suppresses dengue virus infection and providing a new molecular target for dengue virus prevention and treatment. The gene discussed is TXNIP; the disease is dengue disease.